Impact of Transoral Radiofrequency Microsurgery and Radiotherapy on Long-term Swallowing Function in Patients with T1 Glottic Carcinoma

Dysphagia ◽  
2021 ◽  
Author(s):  
Wei Gu ◽  
Jian Wang
2019 ◽  
Vol 139 (9) ◽  
pp. 803-809 ◽  
Author(s):  
Hongli Gong ◽  
Liang Zhou ◽  
Haitao Wu ◽  
Lei Tao ◽  
Xiaoling Chen ◽  
...  

2001 ◽  
Vol 124 (2) ◽  
pp. 225-229 ◽  
Author(s):  
Yau Hui ◽  
Kwok-Man Ma ◽  
William I. Wei ◽  
Wai-Kuen Ho ◽  
Po-Wing Yuen ◽  
...  
Keyword(s):  

2019 ◽  
Vol 128 (9) ◽  
pp. 802-810 ◽  
Author(s):  
Liuba Soldatova ◽  
Natasha Mirza

Objective: Chemoradiation (CRT) for nonlaryngeal head and neck cancer (HNC) can lead to voice and swallowing dysfunction. The purpose of this study was to examine voice and swallowing from the patient’s perspective at least 5 years after treatment. Design: Patient survey. Methods: Twenty-eight patients treated with primary or adjuvant CRT at least 5 years ago (mean = 10.7 years, SD = 5.5, range, 5-28) completed a survey created based on previously validated questionnaires (the Patient Perception of Swallowing Function Questionnaire, PPSFQ; the Eating Assessment Tool, EAT-10; the Voice Handicap Index, VHI-10; the Voice Related Quality of Life, V-RQOL). Results: Patients reported some voice and swallowing dysfunction (39% of V-RQOL scores in categories of fair, poor, or worst possible and 32% of VHI-10 scores ≥20 or greater than 50% of the maximum; 39% of PPSFQ scores greater than 50% of the maximum and 32% of EAT-10 scores ≥20 or 50% of the maximum). There was a correlation between V-RQOL and VHI-10 scores (Pearson product moment correlation coefficient r = .96, calculated probability value p = 0), PPSFQ and EAT-10 scores (r = 0.87, p = 0.8 × 10−8), as well as between V-RQOL and PPSFQ/EAT-10 scores (r = .94, p = 0), VHI-10 and PPSFQ/EAT-10 scores (r = .97, p = 0). Conclusions: Perceived voice and swallowing dysfunction following CRT for nonlaryngeal HNC can persist or worsen beyond 5 years.


Prion ◽  
2020 ◽  
Vol 14 (1) ◽  
pp. 180-184
Author(s):  
Kenjiro Kunieda ◽  
Yuichi Hayashi ◽  
Megumi Yamada ◽  
Masahiro Waza ◽  
Tomonori Yaguchi ◽  
...  

1993 ◽  
Vol 107 (11) ◽  
pp. 1014-1016 ◽  
Author(s):  
J. P. Brooks ◽  
D. W. Morgan ◽  
J. Glaholm

AbstractCarcinoma in Situ (CIS) of the glottis is an uncommon and poorly understood condition with few, large, long- term studies. Twelve cases are presented which were treated with radiotherapy. At three-year follow-up all the patients are disease free and in 83 per cent the mucosa has returned to normal. The alternative methods of treatment are discussed.


2019 ◽  
Vol 73 (3) ◽  
pp. 1-5
Author(s):  
Katarína Vlčková ◽  
Miroslav Tedla

Introduction: Laryngeal cancer and its treatment are associated with both short and long-term side effects, affecting laryngeal functions and having an impact on the quality of life. Material and methods: Retrospective analysis of the medical records of patients receiving surgical or non-surgical, larynx preserving treatment for laryngeal cancer. Results: After termination of the treatment, the highest proportion of patients with bad voice quality was in the glottic carcinoma group (both in early and late phase), with swallowing dysfunction in the transglottic carcinoma group. Compared to the situation before the treatment, the proportion of patients with impaired voice quality (bad voice quality and loss of voice) initially decreased among all groups (except for supraglottic carcinomas), and during the first post-treatment year either increased or hasn’t changed. The proportion of patients with no swallowing dysfunction increased in the supraglottic, subglottic and transglottic carcinoma groups. Discussion: We consider necessary the implementation of a standard pre- and post-treatment monitoring of the voice and swallowing function in the management of patients with laryngeal cancer. Key words laryngeal cancer, functional results, dysphonia, dysphagia, post-treatment follow-up


Sign in / Sign up

Export Citation Format

Share Document